Janus kinase-2 (JAK-2)

Pipeline Summary for Products Targeting Janus kinase-2 (JAK-2)
Print this Phases of Development Preclinical Phase I Phase I/II Phase II Phase III Approved Autoimmune 0 2 0 2 0 0 Cancer 5 2 1 2 0 0 Hematology 0 1 1 3 1 1 Inflammation 0 1 0 0 0 0 Copyright ©2012 BioCentury Publications, Inc. All Rights Reserved